Trusted News Discovery Since 2008
{{/content}}
Oxford COVID shot 'less effective on S.Africa variant'
Video Credit: Reuters Studio
Published on February 7, 2021 - Duration: 01:34s
Oxford COVID shot 'less effective on S.Africa variant'
British drugmaker AstraZeneca said on Saturday (Feb.
6) its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.
Edward Baran reports.
You are here
💡 newsR Knowledge: Other News Mentions
COVID-19
Contagious disease caused by SARS-CoV-2
WHO consultation proposes 'through the air' descriptor for disease transmission, aiming to clarify pathogen transmission methods. Experts like Dr Neeraj Nischal..
Credit: IndiaTimes - Published 3 days ago
Related videos from verified sources
Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose 01:05
Video credit: Wibbitz Top Stories - Published on February 25, 2021
Infectious Disease Expert Says Current COVID Vaccines Provide Some Protection Against UK Variant 02:13
Video credit: CBS4 Miami - Published on February 16, 2021
'Great confidence' in AstraZeneca, despite variants: Johnson 01:01
Video credit: Reuters Studio - Published on February 14, 2021